,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,7.86312325311594e-09,6.4634873140613e-06
2,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Up,2.1240437190439e-05,0.00872981968527043
3,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.00010130672627701,0.0175146511567829
4,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.000105830346226021,0.0175146511567829
5,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.00010653680752301,0.0175146511567829
6,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,7,Up,0.000154709597401039,0.0181673270090935
7,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,7,Up,0.000154709597401039,0.0181673270090935
8,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.000187908091652729,0.0193075564173179
9,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.000237266731248768,0.0216703614540541
10,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,15,Up,0.000415330301872761,0.0341401508139409
11,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.000693426722927913,0.0518178878406131
12,WP_SPHINGOLIPID_PATHWAY,20,Down,0.00111541086643819,0.0764056443510158
13,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.00121662986957494,0.0769284425223537
14,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.00137740038399523,0.0808730796888628
15,WP_COMPLEMENT_ACTIVATION,12,Up,0.00150655322161517,0.0825591165445111
16,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.00220857715219154,0.11346565119384
17,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.0023656261989872,0.114384984445146
18,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.00301574974215839,0.137719238225233
19,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.00361074715408898,0.143391486226851
20,WP_CHOLESTASIS,8,Up,0.00362572873865304,0.143391486226851
21,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.00368757250565533,0.143391486226851
22,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,5,Up,0.00383772834183786,0.143391486226851
23,WP_LIPID_PARTICLES_COMPOSITION,4,Up,0.00596434018271185,0.196797408483289
24,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,18,Down,0.00603895606454528,0.196797408483289
25,WP_COMPLEMENT_SYSTEM,50,Up,0.00633845872907357,0.196797408483289
26,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.00646584891222955,0.196797408483289
27,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.00659981309735698,0.196797408483289
28,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Down,0.00691832825338683,0.196797408483289
29,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.00694297426522553,0.196797408483289
30,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,10,Up,0.00759621453283288,0.202478576584521
31,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.00784549695429486,0.202478576584521
32,WP_SPINAL_CORD_INJURY,63,Down,0.0078823776772563,0.202478576584521
33,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.00923295377114859,0.229984484844974
34,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.0100952514951507,0.244067550853349
35,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.0110823844936552,0.256218950312538
36,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.0115277688734845,0.256218950312538
37,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.0115329697829245,0.256218950312538
38,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.0120694245983236,0.261080711047948
39,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.0127698994497781,0.269150188403016
40,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,40,Up,0.01397606757954,0.279097479148204
41,WP_PROSTAGLANDIN_SIGNALING,21,Down,0.0143703671285228,0.279097479148204
42,WP_PPARALPHA_PATHWAY,15,Up,0.0145262126493753,0.279097479148204
43,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.014599989785125,0.279097479148204
44,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.01575417799446,0.294316688896503
45,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,87,Up,0.016910904429219,0.300778653859472
46,WP_HUNGER_AND_SATIETY,2,Up,0.0170474320798734,0.300778653859472
47,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.0171978062425732,0.300778653859472
48,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.0184217500825295,0.310880847813256
49,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.0185318266944642,0.310880847813256
50,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.0191732592411055,0.315208381923775
51,WP_NEUROINFLAMMATION,10,Down,0.0199849469930111,0.32211032212265
52,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.0209824623278872,0.331684308336987
53,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,32,Down,0.0227530350319869,0.341170173588493
54,WP_16P112_DISTAL_DELETION_SYNDROME,20,Up,0.0230975883247691,0.341170173588493
55,WP_TAR_SYNDROME,43,Down,0.0238195206865666,0.341170173588493
56,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.0245241621497308,0.341170173588493
57,WP_OSTEOBLAST_SIGNALING,3,Down,0.0245767208257605,0.341170173588493
58,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Up,0.024887963692084,0.341170173588493
59,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Down,0.0250572846021611,0.341170173588493
60,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.0252389992439663,0.341170173588493
61,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.0253179812517008,0.341170173588493
62,WP_OPIOID_RECEPTOR_PATHWAYS,24,Down,0.0265427564152401,0.351905576989151
63,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Down,0.0271798700680575,0.354632590411798
64,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,14,Up,0.0278855653954103,0.356154100039819
65,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.0281630371077716,0.356154100039819
66,WP_FOXA2_PATHWAY,9,Up,0.0299777778039146,0.373359596285118
67,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,53,Down,0.0307317364258343,0.377037124507997
68,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.0316027895773723,0.382021956361765
69,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.0322846804691453,0.384608802110688
70,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.0335139114140715,0.393549074033812
71,WP_RETINOBLASTOMA_GENE_IN_CANCER,65,Down,0.0352615482809226,0.408239333618568
72,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.036072221652634,0.409163665680921
73,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.0367628343607133,0.409163665680921
74,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.0368798025068697,0.409163665680921
75,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.0373324512482592,0.409163665680921
76,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.0385532280839287,0.416217608003506
77,WP_BENZOAPYRENE_METABOLISM,5,Up,0.0391504611547482,0.416217608003506
78,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.0395479059572632,0.416217608003506
79,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.040288559907476,0.416217608003506
80,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.0409269125837382,0.416217608003506
81,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.0410141438543601,0.416217608003506
82,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.042250257933001,0.422191782298467
83,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.0429794277137261,0.422191782298467
84,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.0431436857823251,0.422191782298467
85,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.0461341407302652,0.446144278591506
86,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.0469548478420955,0.448800987513983
87,WP_HIPPOYAP_SIGNALING,16,Down,0.0480069893163339,0.453558834255288
88,WP_PROTEASOME_DEGRADATION,57,Down,0.0485561769032425,0.453558834255288
89,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.0496785508778849,0.457700000804175
90,WP_HYPERTROPHY_MODEL,13,Down,0.0502403770649929,0.457700000804175
91,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.0510566090052644,0.457700000804175
92,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.0512267640802727,0.457700000804175
93,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.0521830288739681,0.461230642305395
94,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.0539634671202688,0.46174939664202
95,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Down,0.0540247830419875,0.46174939664202
96,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Up,0.0544773765669208,0.46174939664202
97,WP_DNA_REPLICATION,34,Down,0.0544886757594598,0.46174939664202
98,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.0563087378144262,0.472303902892432
99,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.059349541354942,0.492781040341033
100,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,60,Down,0.0637439391938831,0.523975180173719
101,WP_G1_TO_S_CELL_CYCLE_CONTROL,50,Down,0.0685433505757097,0.55784786310132
102,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,54,Down,0.0693029103406819,0.558499924510201
103,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.0704505785373414,0.559276827636864
104,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.0707600852484597,0.559276827636864
105,WP_OSTEOCLAST_SIGNALING,9,Down,0.0740063459980991,0.568591638063771
106,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.074140124787126,0.568591638063771
107,WP_NRXN1_DELETION_SYNDROME,2,Up,0.0743041950872582,0.568591638063771
108,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,9,Down,0.07470547069451,0.568591638063771
109,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.0771226708125103,0.574601459731764
110,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.077204962914161,0.574601459731764
111,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,8,Up,0.0779114346137149,0.574601459731764
112,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.0782911964598025,0.574601459731764
113,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.0800602164787831,0.582384937571325
114,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Down,0.0867351818844641,0.625406311482715
115,WP_ACUTE_MYELOID_LEUKEMIA,54,Up,0.0900877412667046,0.636369904186737
116,WP_SILDENAFIL_TREATMENT,11,Up,0.0904210701300837,0.636369904186737
117,WP_AGERAGE_PATHWAY,53,Down,0.090578198041178,0.636369904186737
118,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.0964075102465277,0.652741429066703
119,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Down,0.0976751862898093,0.652741429066703
120,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.0984746614376394,0.652741429066703
121,WP_GASTRIN_SIGNALING,91,Down,0.100086064232245,0.652741429066703
122,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.101231512483694,0.652741429066703
123,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.102097976908154,0.652741429066703
124,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.103151737329495,0.652741429066703
125,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.103212808622608,0.652741429066703
126,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.103411148501867,0.652741429066703
127,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.103700561349978,0.652741429066703
128,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.103700561349978,0.652741429066703
129,WP_MEASLES_VIRUS_INFECTION,100,Down,0.104134152657026,0.652741429066703
130,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,37,Up,0.104680922168047,0.652741429066703
131,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.106020263771872,0.652741429066703
132,WP_RETINOL_METABOLISM,6,Down,0.106408409415945,0.652741429066703
133,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.108456205085814,0.652741429066703
134,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Up,0.109105222306651,0.652741429066703
135,WP_KALLMANN_SYNDROME,10,Up,0.110181145410645,0.652741429066703
136,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,12,Down,0.110947138910416,0.652741429066703
137,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.11132052161374,0.652741429066703
138,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.111405225756791,0.652741429066703
139,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Up,0.113384242750032,0.652741429066703
140,WP_ZINC_HOMEOSTASIS,23,Up,0.113561720979951,0.652741429066703
141,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.114079229660427,0.652741429066703
142,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.114124191429372,0.652741429066703
143,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.114184259463427,0.652741429066703
144,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.114427808235349,0.652741429066703
145,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.115142952815903,0.652741429066703
146,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,44,Down,0.117701023205606,0.657505195609819
147,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.118316843435045,0.657505195609819
148,WP_MONOAMINE_TRANSPORT,11,Down,0.118382930596415,0.657505195609819
149,WP_IL1_SIGNALING,52,Down,0.120559282884865,0.66509886262657
150,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.12267456799245,0.670724036390174
151,WP_OMEGA9_FATTY_ACID_SYNTHESIS,9,Up,0.123210863132502,0.670724036390174
152,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.126469329805486,0.680467598648088
153,WP_SYNAPTIC_VESICLE_PATHWAY,21,Down,0.127383595395493,0.680467598648088
154,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.128243776972052,0.680467598648088
155,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.128312016776708,0.680467598648088
156,WP_PPAR_SIGNALING,36,Up,0.129274340968396,0.681176335102701
157,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.130616155463337,0.682047388131841
158,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,29,Up,0.132593133385858,0.682047388131841
159,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.132638523795578,0.682047388131841
160,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.132758615694762,0.682047388131841
161,WP_DRAVET_SYNDROME,11,Down,0.137112134070957,0.692186132672103
162,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,3,Up,0.137383363304312,0.692186132672103
163,WP_CILIARY_LANDSCAPE,182,Down,0.137510179175574,0.692186132672103
164,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.138100396299544,0.692186132672103
165,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.140548942632892,0.694332966888133
166,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.141019923751588,0.694332966888133
167,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.141345487271424,0.694332966888133
168,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.141907467685166,0.694332966888133
169,WP_PYRIMIDINE_METABOLISM,71,Down,0.143540522543418,0.698167512015914
170,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.14782253075655,0.711325861138312
171,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.14797654775505,0.711325861138312
172,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.149973163871008,0.716732213383536
173,WP_IRON_METABOLISM_DISORDERS,10,Up,0.153684766917116,0.730224730669764
174,WP_HISTONE_MODIFICATIONS,35,Up,0.15776201470502,0.735925220928841
175,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,4,Up,0.158099526625137,0.735925220928841
176,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,3,Up,0.158150686419667,0.735925220928841
177,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.15846564976205,0.735925220928841
178,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.163142828067629,0.753389913885342
179,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,12,Down,0.164971400867501,0.757578164877575
180,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.172891164701001,0.778796733656434
181,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.173134603621912,0.778796733656434
182,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Up,0.173516154956326,0.778796733656434
183,WP_PDGF_PATHWAY,36,Down,0.17358083297094,0.778796733656434
184,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Up,0.175277477017116,0.778796733656434
185,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.175523341522684,0.778796733656434
186,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.176224078418609,0.778796733656434
187,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.178890064178686,0.78409077580597
188,WP_GLUCURONIDATION,7,Up,0.179466555692335,0.78409077580597
189,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Up,0.180450640851966,0.78409077580597
190,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.181237527254421,0.78409077580597
191,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.182248155362195,0.784334993234157
192,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.184207749035607,0.788639425558691
193,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.18884963768234,0.804323327331002
194,WP_ECTODERM_DIFFERENTIATION,75,Up,0.190445836740188,0.806940607218734
195,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.1926402491341,0.810465718882479
196,WP_CELL_CYCLE,92,Down,0.19469420301745,0.810465718882479
197,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.194906690442527,0.810465718882479
198,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.195221669511838,0.810465718882479
199,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Down,0.198164156357493,0.814740188138054
200,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.198233622418018,0.814740188138054
201,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.201304594777824,0.816125129574893
202,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Down,0.202185276155024,0.816125129574893
203,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.202268664071726,0.816125129574893
204,WP_OXIDATION_BY_CYTOCHROME_P450,14,Down,0.202542002960192,0.816125129574893
205,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.204542163958581,0.818203807691435
206,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.205493608529371,0.818203807691435
207,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.206044024564631,0.818203807691435
208,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.208814348317749,0.825218241909565
209,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.212892840248185,0.835237945872869
210,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.213381956974821,0.835237945872869
211,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Up,0.217300258672394,0.844537188047508
212,WP_CCL18_SIGNALING,20,Up,0.217812510785975,0.844537188047508
213,WP_MESODERMAL_COMMITMENT_PATHWAY,72,Up,0.220143700783883,0.848000569958129
214,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.220816568615198,0.848000569958129
215,WP_KREBS_CYCLE_DISORDERS,11,Down,0.226055118700577,0.848000569958129
216,WP_EICOSANOID_SYNTHESIS,13,Up,0.226232500642754,0.848000569958129
217,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.226869745033589,0.848000569958129
218,WP_THERMOGENESIS,72,Up,0.228645695377489,0.848000569958129
219,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.229259535055647,0.848000569958129
220,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Down,0.229539072452948,0.848000569958129
221,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.229709763483345,0.848000569958129
222,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Up,0.230006350711738,0.848000569958129
223,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.230053682604213,0.848000569958129
224,WP_G13_SIGNALING,29,Down,0.231293400004602,0.848764173231173
225,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.232396064861044,0.849020290292348
226,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.234146144492028,0.849787555619851
227,WP_APOPTOSIS_MODULATION_AND_SIGNALING,76,Down,0.23486702287982,0.849787555619851
228,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,13,Down,0.236162452274369,0.849787555619851
229,WP_APOPTOSIS,71,Down,0.237739973632993,0.849787555619851
230,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Down,0.239440782990513,0.849787555619851
231,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,28,Down,0.239824316404503,0.849787555619851
232,WP_ENERGY_METABOLISM,41,Up,0.241270621088305,0.849787555619851
233,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.241348230168869,0.849787555619851
234,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.243049758149113,0.849787555619851
235,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.24336996128084,0.849787555619851
236,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.243977935676746,0.849787555619851
237,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.245141458737056,0.850237464480423
238,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.250898119116336,0.866547285351378
239,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.254764663354074,0.87621988818849
240,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.25738765283438,0.878924424732754
241,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.257689521119944,0.878924424732754
242,WP_IDO_METABOLIC_PATHWAY,6,Down,0.261510871503425,0.888272464362872
243,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.265791666824267,0.899097737158632
244,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.267883297667505,0.902248815554033
245,WP_VITAMIN_D_RECEPTOR_PATHWAY,81,Up,0.269569920589803,0.902248815554033
246,WP_SMALL_CELL_LUNG_CANCER,68,Down,0.271191144657541,0.902248815554033
247,WP_ALSTROM_SYNDROME,27,Down,0.275059698753854,0.902248815554033
248,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Up,0.27762013038967,0.902248815554033
249,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.277627534373281,0.902248815554033
250,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.278119247619007,0.902248815554033
251,WP_DNA_DAMAGE_RESPONSE,57,Down,0.278649852980845,0.902248815554033
252,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,73,Down,0.278832771738446,0.902248815554033
253,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.279671574895447,0.902248815554033
254,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Up,0.281038703853853,0.902248815554033
255,WP_COPPER_HOMEOSTASIS,40,Up,0.282756284423054,0.902248815554033
256,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,67,Down,0.282923630729959,0.902248815554033
257,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,14,Up,0.28337248525422,0.902248815554033
258,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Up,0.283722485184392,0.902248815554033
259,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Down,0.284285210740261,0.902248815554033
260,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.290629821730348,0.904863717993843
261,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.291214904594852,0.904863717993843
262,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.291724417991574,0.904863717993843
263,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.291855910927839,0.904863717993843
264,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.294139763563272,0.904863717993843
265,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,19,Up,0.294678816369616,0.904863717993843
266,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.294873192429352,0.904863717993843
267,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.294921170768927,0.904863717993843
268,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.295016394674392,0.904863717993843
269,WP_PROTEOGLYCAN_BIOSYNTHESIS,14,Up,0.302157601722151,0.923321742065457
270,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.305862957263914,0.923612337935446
271,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.30620089151514,0.923612337935446
272,WP_ID_SIGNALING,11,Up,0.306239020634335,0.923612337935446
273,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.306747163328925,0.923612337935446
274,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.311412728812998,0.933345775417792
275,WP_VITAMIN_B12_DISORDERS,9,Down,0.312802686312675,0.933345775417792
276,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.314248041890696,0.933345775417792
277,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.314521629915728,0.933345775417792
278,WP_FERROPTOSIS,49,Up,0.317269474892646,0.933684959173308
279,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.31923086081567,0.933684959173308
280,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Down,0.319753688813693,0.933684959173308
281,WP_NUCLEAR_RECEPTORS,20,Up,0.320165422751955,0.933684959173308
282,WP_MICROTUBULE_CYTOSKELETON_REGULATION,34,Down,0.320315277964565,0.933684959173308
283,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.322841381454399,0.937723023164367
284,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Down,0.325146436074078,0.941092853707368
285,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.328785501529921,0.947447730237368
286,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.329894272369112,0.947447730237368
287,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.331293667188103,0.947447730237368
288,WP_ENDODERM_DIFFERENTIATION,80,Up,0.332268735753102,0.947447730237368
289,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,24,Up,0.333105102236739,0.947447730237368
290,WP_IL17_SIGNALING,25,Up,0.338433805290858,0.956424032647937
291,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.338588069952007,0.956424032647937
292,WP_TARGET_OF_RAPAMYCIN_SIGNALING,31,Down,0.340473650774544,0.958456647043407
293,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.341886504953422,0.959149170893218
294,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.343931747961047,0.961605091238029
295,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,36,Down,0.347072219746485,0.967096151293596
296,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.352528594562125,0.970754881449496
297,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Up,0.354303536584613,0.970754881449496
298,WP_MIRNA_BIOGENESIS,6,Down,0.356778086916132,0.970754881449496
299,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.357997633457219,0.970754881449496
300,WP_LUNG_PATHOLOGY_OF_COVID19,14,Down,0.358123975947252,0.970754881449496
301,WP_BENZENE_METABOLISM,3,Up,0.362880240187691,0.970754881449496
302,WP_ALZHEIMERS_DISEASE,181,Down,0.366891467682246,0.970754881449496
303,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,181,Down,0.366891467682246,0.970754881449496
304,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.367240131898441,0.970754881449496
305,WP_CIRCADIAN_RHYTHM_GENES,114,Down,0.367538450236231,0.970754881449496
306,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,27,Down,0.369533224782901,0.970754881449496
307,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,52,Up,0.369587751070811,0.970754881449496
308,WP_HEPATITIS_B_INFECTION,115,Down,0.370813903705618,0.970754881449496
309,WP_INTEGRATED_CANCER_PATHWAY,39,Up,0.37171046967686,0.970754881449496
310,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.372010662170962,0.970754881449496
311,WP_PREIMPLANTATION_EMBRYO,21,Up,0.372741646483469,0.970754881449496
312,WP_ATR_SIGNALING,10,Down,0.373776894074264,0.970754881449496
313,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.374058378394354,0.970754881449496
314,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.375739003910132,0.970754881449496
315,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Up,0.375801890300189,0.970754881449496
316,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.377466776856617,0.970754881449496
317,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.379656495494701,0.970754881449496
318,WP_CAMKK2_PATHWAY,29,Up,0.380050731164367,0.970754881449496
319,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.381563344361488,0.970754881449496
320,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.382983545326677,0.970754881449496
321,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Up,0.383396897791356,0.970754881449496
322,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.386751939114697,0.970754881449496
323,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Up,0.386892819690501,0.970754881449496
324,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,75,Down,0.38708794017182,0.970754881449496
325,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Down,0.387994905976134,0.970754881449496
326,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.388383337929908,0.970754881449496
327,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.390686810862752,0.970754881449496
328,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.390778339854352,0.970754881449496
329,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Down,0.395949385730618,0.970754881449496
330,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.396030883182491,0.970754881449496
331,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.396350803697712,0.970754881449496
332,WP_PROLACTIN_SIGNALING,69,Down,0.396372562111154,0.970754881449496
333,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.397206848762584,0.970754881449496
334,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.398277905904536,0.970754881449496
335,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.399622564043868,0.970754881449496
336,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.404341681732965,0.970754881449496
337,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.406149616386192,0.970754881449496
338,WP_PARKINSONS_DISEASE_PATHWAY,25,Down,0.406369511466427,0.970754881449496
339,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.406598404288176,0.970754881449496
340,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.408646637784063,0.970754881449496
341,WP_FOXP3_IN_COVID19,9,Up,0.411633468417698,0.970754881449496
342,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,16,Up,0.411825472848936,0.970754881449496
343,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.412650101074985,0.970754881449496
344,WP_MTHFR_DEFICIENCY,18,Up,0.413500411809978,0.970754881449496
345,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.420218496212279,0.970754881449496
346,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Down,0.42074298752705,0.970754881449496
347,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.421929929398717,0.970754881449496
348,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.424623886945182,0.970754881449496
349,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.425463410172514,0.970754881449496
350,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.428397173524062,0.970754881449496
351,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.429301195488011,0.970754881449496
352,WP_OREXIN_RECEPTOR_PATHWAY,114,Down,0.432309376764423,0.970754881449496
353,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,52,Down,0.432449045226773,0.970754881449496
354,WP_CHOLESTEROL_METABOLISM,48,Up,0.434709557144999,0.970754881449496
355,WP_NUCLEAR_RECEPTORS_METAPATHWAY,173,Down,0.435346518240711,0.970754881449496
356,WP_B_CELL_RECEPTOR_SIGNALING,83,Up,0.435889060326964,0.970754881449496
357,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.436995017913154,0.970754881449496
358,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.43707975493941,0.970754881449496
359,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,51,Down,0.437532144997606,0.970754881449496
360,WP_IL26_SIGNALING,31,Down,0.438401135389849,0.970754881449496
361,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.43908158787496,0.970754881449496
362,WP_INSULIN_SIGNALING,125,Down,0.440706095993958,0.970754881449496
363,WP_CHEMOKINE_SIGNALING,106,Up,0.44135276183243,0.970754881449496
364,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.442013106937163,0.970754881449496
365,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.442359805300761,0.970754881449496
366,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Down,0.444780933230722,0.970754881449496
367,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.445414593990151,0.970754881449496
368,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Down,0.44633308570506,0.970754881449496
369,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.448020508564218,0.970754881449496
370,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.448604752696571,0.970754881449496
371,WP_G_PROTEIN_SIGNALING,59,Up,0.450542623748791,0.970754881449496
372,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.450651310200466,0.970754881449496
373,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Up,0.450781685115518,0.970754881449496
374,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Down,0.451963768272038,0.970754881449496
375,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.452265182528538,0.970754881449496
376,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,8,Down,0.457499849840869,0.970754881449496
377,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,18,Up,0.457512670182135,0.970754881449496
378,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,80,Down,0.459973820455186,0.970754881449496
379,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.460093085552658,0.970754881449496
380,WP_NOTCH_SIGNALING_WP268,34,Down,0.460285582717237,0.970754881449496
381,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.461367888993494,0.970754881449496
382,WP_KLEEFSTRA_SYNDROME,25,Up,0.4621733314639,0.970754881449496
383,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Up,0.464361305392365,0.970754881449496
384,WP_GASTRIC_CANCER_NETWORK_1,15,Down,0.464507404237329,0.970754881449496
385,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.465461419766798,0.970754881449496
386,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Up,0.465765401527844,0.970754881449496
387,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Up,0.469171867666044,0.970754881449496
388,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.471411286746198,0.970754881449496
389,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.471610519052998,0.970754881449496
390,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.471740270872374,0.970754881449496
391,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.471994888870324,0.970754881449496
392,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.472296362300655,0.970754881449496
393,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.472332474613764,0.970754881449496
394,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.473365352607324,0.970754881449496
395,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.47416675942693,0.970754881449496
396,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.475559223075648,0.970754881449496
397,WP_SERINE_METABOLISM,5,Down,0.475725180668145,0.970754881449496
398,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.477298620565062,0.970754881449496
399,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.477432323095038,0.970754881449496
400,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.479751882468041,0.970754881449496
401,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,13,Up,0.480477360182562,0.970754881449496
402,WP_NEPHROTIC_SYNDROME,28,Down,0.481388833397248,0.970754881449496
403,WP_METHYLATION_PATHWAYS,5,Up,0.482173011774962,0.970754881449496
404,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Up,0.485462768403103,0.970754881449496
405,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Down,0.490458315352071,0.970754881449496
406,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,6,Up,0.493604639376013,0.970754881449496
407,WP_MEVALONATE_PATHWAY,7,Up,0.494188027099894,0.970754881449496
408,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.494721565421845,0.970754881449496
409,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.494886371756883,0.970754881449496
410,WP_LUNG_FIBROSIS,31,Down,0.494929384179143,0.970754881449496
411,WP_BREAST_CANCER_PATHWAY,82,Down,0.49591836571818,0.970754881449496
412,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.496758656414547,0.970754881449496
413,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.496930687716964,0.970754881449496
414,WP_AUTOPHAGY,27,Down,0.498371015930096,0.970754881449496
415,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.498515601768673,0.970754881449496
416,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.499527578821407,0.970754881449496
417,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.499890415851549,0.970754881449496
418,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.500210140327046,0.970754881449496
419,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.502491144367922,0.970754881449496
420,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,79,Down,0.504827676828199,0.970754881449496
421,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.505404425682142,0.970754881449496
422,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,34,Down,0.507022824649609,0.970754881449496
423,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Up,0.507145322398145,0.970754881449496
424,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Up,0.510667753794802,0.970754881449496
425,WP_SMALL_LIGAND_GPCRS,7,Up,0.511390379722637,0.970754881449496
426,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,26,Down,0.511835305534415,0.970754881449496
427,WP_NRF2_PATHWAY,68,Down,0.511890306263875,0.970754881449496
428,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.513136774810044,0.970754881449496
429,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.516141960076081,0.970754881449496
430,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.516326461306376,0.970754881449496
431,WP_LEPTIN_SIGNALING,69,Down,0.516775893573594,0.970754881449496
432,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.517019495445197,0.970754881449496
433,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.518777773824689,0.970754881449496
434,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Up,0.519447364248173,0.970754881449496
435,WP_MATRIX_METALLOPROTEINASES,7,Down,0.521422294308338,0.970754881449496
436,WP_INTEGRINMEDIATED_CELL_ADHESION,69,Down,0.521763487390013,0.970754881449496
437,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.522739879422108,0.970754881449496
438,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.523513403613057,0.970754881449496
439,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,68,Down,0.528229320369906,0.970754881449496
440,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,16,Up,0.529165477799076,0.970754881449496
441,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.529454039223469,0.970754881449496
442,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.53040525947737,0.970754881449496
443,WP_METABOLIC_EPILEPTIC_DISORDERS,54,Down,0.530859978084941,0.970754881449496
444,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.532145855415966,0.970754881449496
445,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Down,0.532820313981258,0.970754881449496
446,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.533400285830007,0.970754881449496
447,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,12,Up,0.537061038879052,0.970754881449496
448,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,41,Down,0.539293258723478,0.970754881449496
449,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Down,0.540258753495832,0.970754881449496
450,WP_IRINOTECAN_PATHWAY,5,Up,0.543080414646135,0.970754881449496
451,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.543209752861756,0.970754881449496
452,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,64,Up,0.545733997862805,0.970754881449496
453,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.548124282795835,0.970754881449496
454,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.549265544164257,0.970754881449496
455,WP_MELANOMA,53,Down,0.549576818670421,0.970754881449496
456,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.549735967685294,0.970754881449496
457,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.549746430912007,0.970754881449496
458,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.550084519457674,0.970754881449496
459,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Up,0.551937275267134,0.970754881449496
460,WP_MACROPHAGE_MARKERS,8,Up,0.554589288633557,0.970754881449496
461,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.554997860926202,0.970754881449496
462,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.55524233458737,0.970754881449496
463,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,87,Down,0.555340108125345,0.970754881449496
464,WP_CORI_CYCLE,11,Down,0.55791083236559,0.970754881449496
465,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,28,Up,0.560055215111408,0.970754881449496
466,WP_GPCRS_OTHER,11,Up,0.561341509242106,0.970754881449496
467,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Down,0.563326625248469,0.970754881449496
468,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,11,Up,0.563398588427973,0.970754881449496
469,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.563555377803427,0.970754881449496
470,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,10,Up,0.565922617283458,0.970754881449496
471,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.567379695719826,0.970754881449496
472,WP_OSTEOPONTIN_SIGNALING,11,Down,0.567432046114438,0.970754881449496
473,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.567486416839383,0.970754881449496
474,WP_IL9_SIGNALING,15,Up,0.572658031462791,0.970754881449496
475,WP_FOCAL_ADHESION,115,Down,0.573487159351242,0.970754881449496
476,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.574371067078254,0.970754881449496
477,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.574371067078254,0.970754881449496
478,WP_FRAGILE_X_SYNDROME,83,Down,0.575152192077807,0.970754881449496
479,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,2,Down,0.575351943916497,0.970754881449496
480,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.579320573392141,0.970754881449496
481,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.580581474945084,0.970754881449496
482,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.580608235848781,0.970754881449496
483,WP_ONCOSTATIN_M_SIGNALING,52,Down,0.580905986442237,0.970754881449496
484,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.584598588017002,0.970754881449496
485,WP_TROP2_REGULATORY_SIGNALING,41,Up,0.584656681792119,0.970754881449496
486,WP_IL4_SIGNALING,50,Up,0.585957112184787,0.970754881449496
487,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,38,Down,0.58891770723834,0.970754881449496
488,WP_ALLOGRAFT_REJECTION,50,Up,0.590299792467956,0.970754881449496
489,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.591483919556271,0.970754881449496
490,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.591770762749509,0.970754881449496
491,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.592846555336545,0.970754881449496
492,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,266,Up,0.594017661661927,0.970754881449496
493,WP_OVARIAN_INFERTILITY,21,Down,0.596030398522737,0.970754881449496
494,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.596850036371909,0.970754881449496
495,WP_DNA_MISMATCH_REPAIR,21,Down,0.596996221101637,0.970754881449496
496,WP_GLYOXYLATE_METABOLISM,5,Down,0.598001621849111,0.970754881449496
497,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.598291870926184,0.970754881449496
498,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.598302739167074,0.970754881449496
499,WP_BURN_WOUND_HEALING,57,Up,0.599059176726899,0.970754881449496
500,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,55,Up,0.599618309769206,0.970754881449496
501,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.600430472748147,0.970754881449496
502,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,40,Up,0.602371897618289,0.970754881449496
503,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,27,Up,0.603608310081826,0.970754881449496
504,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,51,Down,0.603787027626927,0.970754881449496
505,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.60701205812877,0.970754881449496
506,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,19,Down,0.607521265839009,0.970754881449496
507,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.609311463964119,0.970754881449496
508,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.611620239390039,0.970754881449496
509,WP_GLUTATHIONE_METABOLISM,10,Up,0.613358603054316,0.970754881449496
510,WP_SLEEP_REGULATION,10,Up,0.614160279868888,0.970754881449496
511,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Down,0.614249735984972,0.970754881449496
512,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.615464532627772,0.970754881449496
513,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.615562455654215,0.970754881449496
514,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.615710598779092,0.970754881449496
515,WP_ENDOTHELIN_PATHWAYS,10,Up,0.617109679142762,0.970754881449496
516,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,3,Up,0.6172357756987,0.970754881449496
517,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.617541951037715,0.970754881449496
518,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.618582274137156,0.970754881449496
519,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Down,0.619309514734358,0.970754881449496
520,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Up,0.620032677684691,0.970754881449496
521,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.622213603205081,0.970754881449496
522,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.623343442735876,0.970754881449496
523,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.62370381622678,0.970754881449496
524,WP_TAMOXIFEN_METABOLISM,2,Up,0.626215198495423,0.970754881449496
525,WP_NAD_METABOLISM,12,Down,0.62998362846056,0.970754881449496
526,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.630183551195832,0.970754881449496
527,WP_WNT_SIGNALING_AND_PLURIPOTENCY,56,Up,0.631325020448448,0.970754881449496
528,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.632035704952823,0.970754881449496
529,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Up,0.632621776972737,0.970754881449496
530,WP_RETT_SYNDROME,29,Up,0.632776152304952,0.970754881449496
531,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.63325694383198,0.970754881449496
532,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.634066070362537,0.970754881449496
533,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,31,Up,0.634315840690512,0.970754881449496
534,WP_ANGIOGENESIS,13,Down,0.634767816662184,0.970754881449496
535,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Up,0.634855094393375,0.970754881449496
536,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.635241026335918,0.970754881449496
537,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.638179371651181,0.970754881449496
538,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.638181566299704,0.970754881449496
539,WP_GPCRS_CLASS_A_RHODOPSINLIKE,38,Up,0.639986258711246,0.970754881449496
540,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.642561799107069,0.970754881449496
541,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,36,Up,0.648944465946171,0.970754881449496
542,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,2,Down,0.64916628227915,0.970754881449496
543,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.652522831418863,0.970754881449496
544,WP_ANDROGEN_RECEPTOR_SIGNALING,76,Down,0.654027859612874,0.970754881449496
545,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.655681759541584,0.970754881449496
546,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.655835439696839,0.970754881449496
547,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.658173806107756,0.970754881449496
548,WP_BDNFTRKB_SIGNALING,26,Down,0.658748866809735,0.970754881449496
549,WP_IL3_SIGNALING,46,Up,0.660087975319553,0.970754881449496
550,WP_BARDETBIEDL_SYNDROME,64,Up,0.660508056250768,0.970754881449496
551,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.662288582055143,0.970754881449496
552,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,41,Down,0.662612430319079,0.970754881449496
553,WP_IL5_SIGNALING,37,Up,0.664185079604147,0.970754881449496
554,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.664346546991288,0.970754881449496
555,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,25,Down,0.664899866260748,0.970754881449496
556,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,59,Down,0.665571096496471,0.970754881449496
557,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.666096416253522,0.970754881449496
558,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,32,Up,0.666586368148198,0.970754881449496
559,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.667160404083659,0.970754881449496
560,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.667705393757034,0.970754881449496
561,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.667705393757034,0.970754881449496
562,WP_IL6_SIGNALING,39,Up,0.670304698589829,0.970754881449496
563,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.6714665079532,0.970754881449496
564,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.67326986172685,0.970754881449496
565,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Down,0.674989462529325,0.970754881449496
566,WP_WNT_SIGNALING_WP428,57,Down,0.676570402896553,0.970754881449496
567,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.678068935169932,0.970754881449496
568,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.678252202797101,0.970754881449496
569,WP_ASPIRIN_AND_MIRNAS,8,Up,0.678395149430399,0.970754881449496
570,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.679378622132995,0.970754881449496
571,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.679810580895896,0.970754881449496
572,WP_TCELL_RECEPTOR_SIGNALING,71,Down,0.680487065156053,0.970754881449496
573,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Up,0.683789492168153,0.970754881449496
574,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,167,Up,0.684244749674594,0.970754881449496
575,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.686213900818202,0.970754881449496
576,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.688554210790681,0.970754881449496
577,WP_CILIOPATHIES,120,Up,0.690191075845158,0.970754881449496
578,WP_IL18_SIGNALING,184,Up,0.690239869587515,0.970754881449496
579,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.692072969113091,0.970754881449496
580,WP_PRIMARY_OVARIAN_INSUFFICIENCY,88,Down,0.69323689958278,0.970754881449496
581,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.693343170856208,0.970754881449496
582,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,72,Down,0.694882949962149,0.970754881449496
583,WP_TGFBETA_RECEPTOR_SIGNALING,34,Up,0.695157096645131,0.970754881449496
584,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Down,0.69694375640189,0.970754881449496
585,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.697110116927206,0.970754881449496
586,WP_IL2_SIGNALING,37,Up,0.697413791305651,0.970754881449496
587,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.699653038189554,0.970754881449496
588,WP_IL7_SIGNALING,23,Down,0.700425623154566,0.970754881449496
589,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.701993570064307,0.970754881449496
590,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Down,0.702431746723265,0.970754881449496
591,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.703081279533749,0.970754881449496
592,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.705191791775186,0.970754881449496
593,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.708472788981508,0.970754881449496
594,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.709011308344708,0.970754881449496
595,WP_KININKALLIKREIN_PATHWAY,2,Down,0.711410624943074,0.970754881449496
596,WP_BASE_EXCISION_REPAIR,29,Up,0.713231756005945,0.970754881449496
597,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.713945706289254,0.970754881449496
598,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.715245965623864,0.970754881449496
599,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.718791573812077,0.970754881449496
600,WP_MALE_INFERTILITY,65,Down,0.718873472101586,0.970754881449496
601,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.720138560369378,0.970754881449496
602,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.722409298283385,0.970754881449496
603,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Up,0.724415109041623,0.970754881449496
604,WP_GASTRIC_CANCER_NETWORK_2,24,Up,0.72485807420293,0.970754881449496
605,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,72,Down,0.727501031909686,0.970754881449496
606,WP_PDGFRBETA_PATHWAY,26,Down,0.729058780585974,0.970754881449496
607,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.72963673444883,0.970754881449496
608,WP_PLEURAL_MESOTHELIOMA,242,Down,0.729671290258709,0.970754881449496
609,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,58,Up,0.730776652885287,0.970754881449496
610,WP_TP53_NETWORK,16,Up,0.731237595098694,0.970754881449496
611,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,79,Up,0.731609507106603,0.970754881449496
612,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,10,Down,0.731755833275548,0.970754881449496
613,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.73264792921633,0.970754881449496
614,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.733769496058463,0.970754881449496
615,WP_NRF2ARE_REGULATION,20,Up,0.736187507031097,0.970754881449496
616,WP_JOUBERT_SYNDROME,70,Down,0.736468334854708,0.970754881449496
617,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Down,0.737704924784102,0.970754881449496
618,WP_GLIOBLASTOMA_SIGNALING,64,Down,0.738983452410048,0.970754881449496
619,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,12,Down,0.742000234133883,0.970754881449496
620,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.742002723855171,0.970754881449496
621,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Down,0.742911454599565,0.970754881449496
622,WP_MONOAMINE_GPCRS,3,Up,0.743430755030033,0.970754881449496
623,WP_EGFEGFR_SIGNALING,135,Down,0.744140776095445,0.970754881449496
624,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Up,0.744736507605759,0.970754881449496
625,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Up,0.747128382050806,0.970754881449496
626,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.748167550991803,0.970754881449496
627,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.7500336092748,0.970754881449496
628,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.750566707929781,0.970754881449496
629,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.751643532472955,0.970754881449496
630,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.751668945836248,0.970754881449496
631,WP_PURINERGIC_SIGNALING,14,Up,0.754756340859452,0.970754881449496
632,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.755201475814048,0.970754881449496
633,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,11,Down,0.756816916009819,0.970754881449496
634,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.757545867596575,0.970754881449496
635,WP_P38_MAPK_SIGNALING,31,Down,0.75769267831768,0.970754881449496
636,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.759312657946,0.970754881449496
637,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.761242048833831,0.970754881449496
638,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.763566256429599,0.970754881449496
639,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,27,Down,0.764061807195799,0.970754881449496
640,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.764692732417434,0.970754881449496
641,WP_NEOVASCULARIZATION_PROCESSES,21,Down,0.764991649162913,0.970754881449496
642,WP_ACE_INHIBITOR_PATHWAY,4,Up,0.765127274418604,0.970754881449496
643,WP_BLADDER_CANCER,28,Down,0.768568648915621,0.970754881449496
644,WP_NOTCH_SIGNALING_WP61,47,Down,0.76862966477982,0.970754881449496
645,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.768738300991947,0.970754881449496
646,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,24,Up,0.769413906661088,0.970754881449496
647,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.773348434928321,0.970754881449496
648,WP_TRANSSULFURATION_PATHWAY,8,Up,0.773603343491814,0.970754881449496
649,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,62,Down,0.776795908551785,0.970754881449496
650,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Up,0.778980073472048,0.970754881449496
651,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.779225203339477,0.970754881449496
652,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Up,0.779975325020236,0.970754881449496
653,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.782288577476693,0.970754881449496
654,WP_KIT_RECEPTOR_SIGNALING,49,Up,0.782472286186126,0.970754881449496
655,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Up,0.782926278105568,0.970754881449496
656,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Down,0.783246234929879,0.970754881449496
657,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.783303718129356,0.970754881449496
658,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.783523556664624,0.970754881449496
659,WP_VITAMIN_B12_METABOLISM,23,Up,0.784683677904036,0.970754881449496
660,WP_VEGFAVEGFR2_SIGNALING,331,Up,0.787589438914376,0.970754881449496
661,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.787655003849514,0.970754881449496
662,WP_PEPTIDE_GPCRS,11,Up,0.787919966698188,0.970754881449496
663,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Down,0.788165831048852,0.970754881449496
664,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.789736847346638,0.970754881449496
665,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.790086976951825,0.970754881449496
666,WP_ATM_SIGNALING,33,Down,0.79147153431085,0.970754881449496
667,WP_TRYPTOPHAN_METABOLISM,17,Up,0.791573865885638,0.970754881449496
668,WP_RAC1PAK1P38MMP2_PATHWAY,50,Down,0.793794916196174,0.970754881449496
669,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.795478246161906,0.970754881449496
670,WP_PI3KAKT_SIGNALING,172,Up,0.797653713970126,0.970754881449496
671,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,48,Up,0.798925337487097,0.970754881449496
672,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,3,Up,0.799136360932352,0.970754881449496
673,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.800565382342934,0.970754881449496
674,WP_AEROBIC_GLYCOLYSIS,9,Down,0.800918434323141,0.970754881449496
675,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,9,Down,0.800918434323141,0.970754881449496
676,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,22,Down,0.80092269329331,0.970754881449496
677,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Up,0.801275394955645,0.970754881449496
678,WP_MAPK_SIGNALING,160,Down,0.801474565175906,0.970754881449496
679,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.804285515164843,0.970754881449496
680,WP_CELLULAR_PROTEOSTASIS,6,Down,0.806334182988747,0.970754881449496
681,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.806871373400165,0.970754881449496
682,WP_NPHP1_DELETION_SYNDROME,10,Up,0.807066750923313,0.970754881449496
683,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,11,Down,0.809908985107618,0.970754881449496
684,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.809914752977583,0.970754881449496
685,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.812087908018558,0.970754881449496
686,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,35,Down,0.812533630434613,0.970754881449496
687,WP_MRNA_PROCESSING,124,Up,0.81273081914435,0.970754881449496
688,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.813242382935907,0.970754881449496
689,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.815970791531178,0.970754881449496
690,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.816938804675792,0.970754881449496
691,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.821589794965156,0.970754881449496
692,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.821992848722796,0.970754881449496
693,WP_IL11_SIGNALING,40,Up,0.822011359598785,0.970754881449496
694,WP_MAPK_CASCADE,30,Up,0.823662720080912,0.970754881449496
695,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.824615699593739,0.970754881449496
696,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.824728083171719,0.970754881449496
697,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.8254974368607,0.970754881449496
698,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,9,Down,0.82667262932527,0.970754881449496
699,WP_VITAMIN_D_METABOLISM,5,Down,0.829234362016985,0.970754881449496
700,WP_ARYLAMINE_METABOLISM,1,Up,0.831052915141256,0.970754881449496
701,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,19,Down,0.83262192456581,0.970754881449496
702,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Up,0.833531299264799,0.970754881449496
703,WP_HIPPO_SIGNALING_REGULATION,42,Down,0.833867030021929,0.970754881449496
704,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,84,Down,0.835500206868186,0.970754881449496
705,WP_NEPHROGENESIS,4,Up,0.83723668186539,0.970754881449496
706,WP_CYTOSINE_METHYLATION,7,Up,0.837725684880356,0.970754881449496
707,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.838272970470818,0.970754881449496
708,WP_FOLATE_METABOLISM,36,Down,0.839585634450365,0.970754881449496
709,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,64,Down,0.840058602050654,0.970754881449496
710,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.840792601203128,0.970754881449496
711,WP_NUCLEOTIDE_GPCRS,6,Up,0.842009603283259,0.970754881449496
712,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,9,Down,0.842735057100942,0.970754881449496
713,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.842920326471784,0.970754881449496
714,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Up,0.84321044447073,0.970754881449496
715,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Up,0.845307911740511,0.971808536294686
716,WP_GPCRS_CLASS_B_SECRETINLIKE,3,Up,0.848546559218275,0.973280201574062
717,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,25,Up,0.84953037502007,0.973280201574062
718,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.851421621320706,0.973280201574062
719,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,112,Down,0.851841183400869,0.973280201574062
720,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.852508205758302,0.973280201574062
721,WP_TRANSLATION_FACTORS,49,Down,0.857950732922839,0.977011099272721
722,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.85815330130767,0.977011099272721
723,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.861011841161938,0.978103714459807
724,WP_NETRINUNC5B_SIGNALING,35,Down,0.862235118308265,0.978103714459807
725,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.862682716524769,0.978103714459807
726,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.867132342448782,0.980968700710199
727,WP_WNT_SIGNALING_WP363,36,Down,0.871040417660621,0.980968700710199
728,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.871341509697785,0.980968700710199
729,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,62,Up,0.87168212122021,0.980968700710199
730,WP_ADIPOGENESIS,82,Up,0.873012721952794,0.980968700710199
731,WP_STEROID_BIOSYNTHESIS,2,Down,0.87307996688084,0.980968700710199
732,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,86,Up,0.873563368515652,0.980968700710199
733,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Down,0.876197896994951,0.982584817639631
734,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,29,Up,0.878848266162127,0.984214270824616
735,WP_AMINO_ACID_METABOLISM,57,Down,0.8830211331992,0.986246648451386
736,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Down,0.883062692530681,0.986246648451386
737,WP_HEART_DEVELOPMENT,15,Up,0.88607508469066,0.986265128179697
738,WP_ESTROGEN_SIGNALING,21,Down,0.887371080818466,0.986265128179697
739,WP_ERBB_SIGNALING,66,Down,0.887801702585893,0.986265128179697
740,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,85,Down,0.887878582546199,0.986265128179697
741,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.890494318414063,0.987721283660691
742,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.892346525574787,0.987721283660691
743,WP_CREATINE_PATHWAY,1,Down,0.892794298977972,0.987721283660691
744,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.895843534070843,0.98916145190914
745,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.899287693753985,0.98916145190914
746,WP_TGFB_SMAD_SIGNALING,7,Up,0.900367745312341,0.98916145190914
747,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.900549943106915,0.98916145190914
748,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,10,Down,0.90055784434193,0.98916145190914
749,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.90237624872587,0.98916145190914
750,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.903228290121803,0.98916145190914
751,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Up,0.90529254962906,0.98916145190914
752,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Down,0.907186316957301,0.98916145190914
753,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Up,0.908995387091261,0.98916145190914
754,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Down,0.909978260395058,0.98916145190914
755,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Down,0.91363391561478,0.98916145190914
756,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.91413101043163,0.98916145190914
757,WP_RANKLRANK_SIGNALING,47,Up,0.915623767705341,0.98916145190914
758,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,122,Up,0.915741945572212,0.98916145190914
759,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.915876383314106,0.98916145190914
760,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.916200141117129,0.98916145190914
761,WP_UREA_CYCLE_AND_RELATED_DISEASES,2,Down,0.916253070806426,0.98916145190914
762,WP_ENDOMETRIAL_CANCER,48,Up,0.918075105482706,0.98916145190914
763,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.918163245506903,0.98916145190914
764,WP_VALPROIC_ACID_PATHWAY,8,Down,0.921343877571178,0.9910068089189
765,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Up,0.925796880497909,0.9910068089189
766,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.926106458957575,0.9910068089189
767,WP_HEME_BIOSYNTHESIS,8,Down,0.926106458957575,0.9910068089189
768,WP_GPR40_PATHWAY,8,Down,0.926416250196284,0.9910068089189
769,WP_ONECARBON_METABOLISM,22,Down,0.927363754973964,0.9910068089189
770,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.930622717034218,0.9910068089189
771,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,13,Down,0.930782209614084,0.9910068089189
772,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.932003152529006,0.9910068089189
773,WP_ESTROGEN_METABOLISM_WP697,5,Down,0.932534708471784,0.9910068089189
774,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,59,Up,0.933615335388817,0.9910068089189
775,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.934343402569523,0.9910068089189
776,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.937876740052193,0.991232359061829
777,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.939304203984321,0.991232359061829
778,WP_NONSMALL_CELL_LUNG_CANCER,57,Up,0.940817071949115,0.991232359061829
779,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.941909470670948,0.991232359061829
780,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.946235955464932,0.991232359061829
781,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.946305617503641,0.991232359061829
782,WP_PTF1A_RELATED_REGULATORY_PATHWAY,5,Up,0.953135353818045,0.991232359061829
783,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.954200822287892,0.991232359061829
784,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.954296234320797,0.991232359061829
785,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.955508180675928,0.991232359061829
786,WP_TCA_CYCLE_IN_SENESCENCE,9,Down,0.957138156062803,0.991232359061829
787,WP_ACUTE_VIRAL_MYOCARDITIS,63,Up,0.958312211397389,0.991232359061829
788,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.959213504810152,0.991232359061829
789,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,47,Down,0.959369652814192,0.991232359061829
790,WP_RAS_SIGNALING,113,Down,0.959533902048453,0.991232359061829
791,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.961296355497061,0.991232359061829
792,WP_DOPAMINE_METABOLISM,7,Down,0.961315084040513,0.991232359061829
793,WP_PURINE_METABOLISM,10,Down,0.962641074353948,0.991232359061829
794,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.963141410575744,0.991232359061829
795,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,29,Up,0.963714101655103,0.991232359061829
796,WP_SPINA_BIFIDA,10,Down,0.964556397415493,0.991232359061829
797,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Up,0.964794323437946,0.991232359061829
798,WP_MELATONIN_METABOLISM_AND_EFFECTS,18,Up,0.965711086177915,0.991232359061829
799,WP_AXON_GUIDANCE,35,Down,0.967188738107426,0.991232359061829
800,WP_NEURAL_CREST_DIFFERENTIATION,35,Up,0.967291320439698,0.991232359061829
801,WP_TNFALPHA_SIGNALING,83,Down,0.967433535835308,0.991232359061829
802,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.968416480123173,0.991232359061829
803,WP_SEROTONIN_AND_ANXIETY,5,Up,0.96858342804206,0.991232359061829
804,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Up,0.969526540980183,0.991232359061829
805,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,133,Down,0.97260093302376,0.991832072071537
806,WP_PRION_DISEASE_PATHWAY,27,Up,0.974192455458676,0.991832072071537
807,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.976594398301572,0.991832072071537
808,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.976594398301572,0.991832072071537
809,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.977254812920669,0.991832072071537
810,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Down,0.977352771749325,0.991832072071537
811,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.978798076825032,0.992074006350402
812,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.980975997909882,0.992887170690368
813,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,46,Up,0.98201614327405,0.992887170690368
814,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.983274572206463,0.99293820436574
815,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.984846284176192,0.993305086616969
816,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.988295746011152,0.994554690817954
817,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.989398033913101,0.994554690817954
818,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.989828256108368,0.994554690817954
819,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,14,Up,0.990924929172633,0.994554690817954
820,WP_CANCER_PATHWAYS,292,Down,0.994640874968956,0.997066828322538
821,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Up,0.996143696498513,0.997357026214102
822,WP_IL19_SIGNALING,20,Up,0.999129841428032,0.999129841428032
